We continue to believe that harnessing stem cells, gene therapy, and neuroregenerative approaches will be important to the successful treatment of neurological and sensory disorders.The report covers developments at more than 125 organizations and provides in-depth profiles of twenty five companies with an especially important role in shaping the field, namely: Advanced Cell Technology, ArunA Bio